ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

エメダスチン

Emedastine

HCID 3219
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
87233-61-2
標準SMILES
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21
InChIKey
KBUZBQVCBVDWKX-UHFFFAOYSA-N
分子式
C17H26N4O
平均分子量
302.4 g/mol
単同位体質量
302.21066145

概要

Emedastine is 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis. It has a role as a H1-receptor antagonist, an anti-allergic agent and an antipruritic drug.

名称と識別子

優先名称
Emedastine
IUPAC
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
現地名
エメダスチン
英語名
Emedastine
分子式
C17H26N4O
分子量
302.41

名称と別名

emedastine87233-61-2EmedastinaEmedastinum1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole9J1H7Y9OJV1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazoleCHEBI:4779DTXSID70482431-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-
名称をさらに表示
エメダスチン1-(2-エトキシエチル)-2-(4-メチルヘキサヒドロ-1H-1,4-ジアゼピン-1-イル)-1H-ベンゾイミダゾール1-(2-エトキシエチル)-2-[(ヘキサヒドロ-4-メチル-1H-1,4-ジアゼピン)-1-イル]-1H-ベンゾイミダゾール1-(2-エトキシエチル)-2-(4-メチル-1,4-ジアゼパン-1-イル)-1H-1,3-ベンゾジアゾールEmestineEmedastine impurity FEmedastinc Impurity CEmedastine Impurity CEmedastine Impurity 14Emedastine, 10 mM in DMSO1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole
KG 24131-(2-(ethoxy)ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole1-(2-Ethoxy-ethyl)-2-(4-methyl-(1,4)diazepan-1-yl)-1H-benzoimidazoleRefChem:590745DTXCID8028218S01GX06Emedastine [INN]Emedastinum [INN-Latin]

物性

構造計算による物性補完中

XLogP
2.2
極性表面積
33.5 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
5
重原子数
22
形式電荷
0
複雑度
341

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.6
Solubility · 2 件

Soluble (difumarate formulation)

1.44e+00 g/L

Human Drugs · 2 件

Breast Feeding; Lactation; Milk, Human; Antihistamines

EMA approved medicines: Human medicine

Physical DescriptionSolid

物理化学的性質

沸点
446.6 · 446.6±55.0 °C(Predicted)
比重(密度)
1.15 · 1.15±0.1 g/cm3(Predicted)
貯蔵温度
2 · 2-8°C
溶解性
125 mg/mL · DMSO: 125 mg/mL (413.35 mM); Ethanol: 100 mg/mL (330.68 mM)
酸解離定数(Pka)
8.86 · 8.86±0.10(Predicted)
外見
Viscous Liquid
色
Yellow to brown
CAS データベース
87233 · 87233-61-2(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

化学と産業

薬理情報

ATC Code · 3 件

S01GX06

S - Sensory organs

QS - Sensory organs

PharmacodynamicsEmedastine is a relatively selective H<sub>1</sub>-receptor antagonist.
Mechanism of Action · 1 件

Emedastine is a relatively selective, histamine H<sub>1</sub> antagonist. In vitro examinations of emedastine's affinity for histamine receptors demonstrate relative selectivity for the H<sub>1</sub> histamine receptor. In vivo studies have shown concentration-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Emedastine appears exert negligible effects on adrenergic, dopaminergic and serotonin receptors.

Biological Half-LifeThe elimination half-life in the plasma is 3-4 hours following oral administration.
Metabolism/MetabolitesTwo primary metabolites, 5-hydroxyemedastine and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms. Minor metabolites include the 5'-oxoanalogs of 5-hydroxyemedastine and 6-hydroxy-emedastine and the N-oxide.
FDA Pharmacological Classification · 5 件

9J1H7Y9OJV

EMEDASTINE

Mechanisms of Action [MoA] - Histamine H1 Receptor Antagonists

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Inhibitor

Emedastine is a Histamine-1 Receptor Inhibitor. The mechanism of action of emedastine is as a Histamine H1 Receptor Antagonist.

MeSH Pharmacological Classification · 2 件

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

関連反応

10 件
反応記録を作成
HRID 149394 の反応式
HRID 149394反応物として
HRID 197660 の反応式
HRID 197660生成物として
HRID 637016 の反応式
HRID 637016生成物として
HRID 637017 の反応式
HRID 637017反応物として
HRID 1388162 の反応式
HRID 1388162生成物として
HRID 1546942 の反応式
HRID 1546942生成物として反応物として
HRID 1584426 の反応式
HRID 1584426生成物として
HRID 1584427 の反応式
HRID 1584427反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
87233-61-2
PubChem CID
3219
DTXSID
DTXSID7048243
ChEMBL
CHEMBL594
ChEBI
CHEBI:4779
UNII
9J1H7Y9OJV
Nikkaji
J253.163A

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2 件

Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.

Following oral administration, approximately 44% of the total dose can be recovered in the urine over the 24-hour period, with only 3.6% of the dose excreted as unchanged form. Two primary metabolites, 5- and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms.

Cellular LocationsMembrane
Metabolite PathwaysEmedastine H1-Antihistamine Action

応用分野

用途ヒスタミンH 拮抗薬アレルギー性鼻炎,蕁麻疹,アトピー性皮膚炎

使用Antihistaminic, H1-receptor; asthma prophylactic; anti-allergic.

上流・下流製品情報

上流原料

N-(2-エトキシエチル)-o-ベンゼンジアミンN-(2-エトキシエチル)-2-ニトロアニリンEMEDASTINE IMPURITY E1-(2-Ethoxy-ethyl)-1,3-dihydro-benzoimidazol-2-one1-(2-エトキシエチル)-2-クロロ-1H-ベンゾイミダゾール1,4-ジアゼパン-1-カルボン酸TERT-ブチル1-メチルホモピペラジン2-クロロベンゾイミダゾールアニリンホルマリン2-クロロニトロベンゼン
補足説明 · 1 件

定義ChEBI: 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the ifumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.